Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05506644 · ClinicalTrials.gov registry record · NA
Biofeedback for Psoriasis
A NA study, sponsored by Bastyr University.
- Completed
- Registry status
- NA
- Development phase
- 5
- Enrollment target
NCT05506644: Completed NA study, sponsored by Bastyr University.
NCT05506644 is a NA study that has completed, run by Bastyr University. The registered enrollment target is 5 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05506644, a NA study, has completed, sponsored by Bastyr University.
- COMPLETED
- Registry status
- NA
- Development phase
- 5 participants
- Enrollment target
Study Summary
We are conducting a proof-of-concept trial to study the impact of HRV-biofeedback, a mind-body technique designed to improve stress resilience, on the quality of life, mood, and clinical skin severity of patients with psoriasis.
Interventions
- OTHER HRV-Biofeedback/Mind-Body Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2022-06-07 |
| Est. Completion | 2023-03-31 |
| Phase | NA |
What the finished NCT05506644 record still lists
NCT05506644 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 5 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which HRV-Biofeedback/Mind-Body Therapy is the first listed.
NCT05506644 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05506644 about?
NCT05506644 is a clinical study titled "Biofeedback for Psoriasis". We are conducting a proof-of-concept trial to study the impact of HRV-biofeedback, a mind-body technique designed to improve stress resilience, on the quality of life, mood, and clinical skin severity of patients with psoriasis.
What is the current status of trial NCT05506644?
This trial is currently completed. It is a NA study. The enrollment target is 5 participants. The study started on 2022-06-07. Estimated completion is 2023-03-31.
What interventions are being tested in trial NCT05506644?
The interventions under investigation include: HRV-Biofeedback/Mind-Body Therapy (OTHER).
Who is sponsoring clinical trial NCT05506644?
This trial is sponsored by Bastyr University, which has 19 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05506644's enrollment target sits among peer trials
5 1988th of 2000 higher than 5 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI